Business area digitalisation analysis

Specialised healthcare service centres: digitalisation analysis

How to digitalise a single specialised service patient pathway, clinical protocols, diagnostics and continuous monitoring

Digital maturity

Typical digital maturity

Shows the level of digitalisation companies in this line of business typically operate at.

The assessment considers use of core systems, how far processes are digitalised, integrations, data readiness and advanced use of data.

A 3 means ordinary, middling maturity. A 5 is given only where real-time data, automated decisions and advanced optimisation are already a routine part of core operations.

average
Digitalisation potential

Digitalisation potential

Shows the scale of business impact digitalisation could have in this line of business.

It weighs economic leverage, the scope for digital impact, the scale and repetition of processes, value lost today, and the leverage of better data and decisions.

A business area’s score is calculated from five weighted dimensions. A sector’s score is derived from the scores of its business areas.

88/100
Biggest challenge
Specialised treatment pathway fragmented across stages
Biggest opportunity
Protocol-based digital specialist treatment pathway

The greatest value lies in reliable execution of a specific specialised treatment pathway, not in a universal platform for all specialties.

How specialised health service centres operate

The business area encompasses fertility, ophthalmology, dermatology, oncology, dialysis, pain, sleep, genetics and other centres where the patient undergoes a deep care pathway governed by specialty-specific rules.

The clinical pathway is more in-depth than in general outpatient care

A single patient may progress through many stages of examinations, procedures, documentation and decisions over an extended period.

The protocol has rules and exceptions

The system must support the execution of the standard, but cannot override the specialist's decision or individual deviation.

Multi-disciplinary decisions require a unified context

Specialist reports, images, investigations and consilium decisions must be visible in a single traceable file.

Outcomes are often assessed from a long-term perspective

What matters is not only the fact of the procedure, but also biomarkers, function, patient-reported KPIs and follow-up results.

Market and technology context

Digitalisation of specialised centres is shaped by clinical pathway management, structured protocols, multidisciplinary decisions, e-consents, remote monitoring and AI assistance validated only for a specific purpose.

  • Complex pathways require visible statuses and deadlinesThe more stages and participants, the higher the risk of a missed test, document or control action.
  • Protocol version must be traceableIt is important to know which rules applied to a specific patient and why an exception was chosen.
  • Multidisciplinary care transitions to structured workflowCouncil materials, findings, decision and responsibilities must be prepared before the meeting and closed after it.
  • Remote monitoring increases data volumeQuestionnaires, sensors and biomarkers are useful only when it is clear which changes should trigger a specialist action.

Typical specialised treatment pathway

01

Referral, registration and eligibility verification

Clinical context and previous tests are collected, and whether the patient meets the criteria for the selected pathway is determined.

02

Initial specialist examination

Essential tests, imaging, questionnaires and risk assessment are carried out according to the specific specialty.

03

Care pathway and protocol selection

A specialist or team determines the stages, deadlines, documents, consents and possible exceptions.

04

Multidisciplinary decision or procedure execution

Specialist findings, preparation, intervention, medication and related documents are brought together.

05

Follow-up and long-term monitoring

Clinical, laboratory, or patient-reported KPIs are collected and response to treatment is assessed.

06

Pathway correction or completion

Based on the outcome, the protocol is modified, the next stage is assigned, the patient is returned to a partner, or the active pathway is completed.

Digital maturity model

0

Pathway managed by documents and staff knowledge

Protocol stages, consents, councils and control deadlines depend on paper, files and specialist memory.

1

Specialised clinical system without unified pathway

Core records are digital, but stages, document versions, multidisciplinary decisions and monitoring are managed separately.

2

Individual protocol stages digitalised

E-consents, council modules or patient questionnaires are in place, but there is no single valid pathway status and responsibility model.

3

Key stages of one specialised pathway linked Typical current situation

In selected care pathways, eligibility, tests, protocol version, documents, multidisciplinary decision, procedure and control are linked, but different patient groups and exceptions are still managed inconsistently.

4

Data-driven quality and long-term outcomes Target

The centre monitors deadlines, protocol deviations, incomplete actions, capacity, complications and long-term outcome KPIs in real time.

5

Securely personalised clinical pathway

AI and advanced analytics help review data or suggest pathway corrections, but decisions are confirmed by a specialist, and the model's impact is continuously monitored.

Key finding

Specialised centres create the greatest value not in individual consultations, but by consistently delivering a long, protocol-based patient pathway.

The system must help visualise which stage has been completed, what data is missing, which protocol version is applied, who made the decision and when the next action is required.

The first version should cover one clearly defined clinical pathway and one patient group, rather than attempting to standardise all specialised services.

Related topics

Patient self-service portalClinical process managementFHIR integration

Creating a reliable pathway for one specialised treatment

A specific patient group, protocol stages, decision points and data flows will be reviewed, helping to define a safe first version.